New Search

Your search found 158 records, sorted by year and then date of acquisition.

1. The Prescription Opioid Addiction Treatment Study: What Have We Learned. doc type
  Weiss, Roger D. ; Rao, Vinod
 Drug and Alcohol Dependence 2017;173:S48-S54. [doi: 10.1016/j.drugalcdep.2016.12.001].
 
2. Volatility and Change in Chronic Pain Severity Predict Outcomes of Treatment for Prescription Opioid Addiction. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Addiction 2017 (in press). [doi: 10.1111/add.13782].
 
3. Distinctive Trajectories of Opioid Use Over an Extended Follow-Up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone. doc type
  Hser, Yih-Ing ; Huang, David ; Saxon, Andrew J. ; Woody, George ; Moskowitz, Andrew L. ; Matthews, Abigail G. ; Ling, Walter
 Journal of Addiction Medicine 2017;11(1):63-69. [doi: 10.1097/ADM.0000000000000274].
 
4. The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. doc type
  Carroll, Kathleen M. ; Weiss, Roger D.
 American Journal of Psychiatry 2016 (in press). [doi: 10.1176/appi.ajp.2016.16070792].
 
5. A Polymorphism in the OPRM1 3'-Untranslated Region is Associated with Methadone Efficacy in Treatment Opioid Dependence. doc type
  Crist, Richard C. ; Doyle, Glenn A. ; Nelson, Elliot C. ; Degenhardt, Louisa ; Martin, Nicholas G. ; Montgomery, Grant W. ; Saxon, Andrew J. ; Ling, Walter ; Berrettini, Wade H.
 Pharmacogenomics Journal 2016 (in press). [doi: 10.1038/tpj.2016.89].
 
6. CSAT/CTN Webinar: Adolescent/Youth Projects Updates. doc type
  Johnson, Kimberly ; Fishman, Marc ; Levy, Sharon
 Webinar presented November 29, 2016.
 
7. Ethical and Clinical Safety Considerations in the Design of an Effectiveness Trial: A Comparison of Buprenorphine Versus Naltrexone Treatment for Opioid Dependence. doc type
  Nunes, Edward V. ; Lee, Joshua D. ; Sisti, Dominic ; Segal, Andrea ; Caplan, Arthur ; Fishman, Marc J. ; Bailey, Genie L. ; Brigham, Gregory S. ; Novo, Patricia ; Farkas, Sarah ; Rotrosen, John
 Contemporary Clinical Trials 2016;51:34-43. [doi: 10.1016/j.cct.2016.09.006].
 
8. NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale. doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bailey, Genie L. ; Brigham, Gregory S. ; Cohen, Allan J. ; Fishman, Marc J. ; Ling, Walter ; Lindblad, Robert ; Shmueli-Blumberg, Dikla ; Stablein, Don ; May, Jeanine ; Salazar, Dagmar ; Liu, David S. ; Rotrosen, John
 Contemporary Clinical Trials 2016;50:253-264. [doi: 10.1016/j.cct.2016.08.004].
 
9. Changes in Quality of Life in Cocaine-Dependent Participants Provided Treatment with Buprenorphine+Naloxone Combined with Extended Release Naltrexone. doc type
  Shmueli-Blumberg, Dikla ; Carrizales, Fermin A. ; Kazanis, William H. ; Hillhouse, Maureen ; Matthews, Abigail ; Potter, Jennifer Sharpe
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
10. Participant Treatment Assignment Perceptions in the NIDA CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Matthews, Abigail G. ; Hillhouse, Maureen ; Thomas, Christie ; Ling, Walter ; Shmueli-Blumberg, Dikla
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
11. Longitudinal Association Between Pain Severity and Subsequent Opioid Use in Prescription Opioid Dependent Patients with Chronic Pain. doc type
  Griffin, Margaret L. ; McDermott, Katherine A. ; McHugh, R. Kathryn ; Fitzmaurice, Garrett M. ; Jamison, Robert N. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2016;163(1):216-221. [doi: 10.1016/j.drugalcdep.2016.04.023].
 
12. Buprenorphine-Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Mooney, Larissa J. ; Thomas, Christie ; Ang, Alfonso ; Matthews, Abigail G. ; Hasson, Albert L. ; Annon, Jeffrey J. ; Sparenborg, Steven ; Liu, David S. ; McCormack, Jennifer ; Church, Sarah ; Swafford, William ; Drexler, Karen ; Schuman, Carolyn ; Ross, Stephen ; Wiest, Katharina L. ; Korthuis, P. Todd ; Lawson, William ; Brigham, Gregory S. ; Knox, Patricia C. ; Dawes, Michael ; Rotrosen, John
 Addiction 2016;111(8):1416-1427. [doi: 10.1111/add.13375].
 
13. Long-Term Outcomes After Randomization to Buprenorphine/Naloxone Versus Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Evans, Elizabeth ; Huang, David ; Weiss, Roger D. ; Saxon, Andrew J. ; Carroll, Kathleen M. ; Woody, George E. ; Liu, David S. ; Wakim, Paul G. ; Matthews, Abigail G. ; Hatch-Maillette, Mary A. ; Jelstrom, Eve ; Wiest, Katharina L. ; McLaughlin, Paul ; Ling, Walter
 Addiction 2016;111(4):695-705. [doi: 10.1111/add.13238].
 
14. Pain Volatility and Prescription Opioid Addiction Treatment Outcomes in Patients With Chronic Pain. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Experimental and Clinical Psychopharmacology 2015;23(6):428-435. [doi: 10.1037/pha0000039].
 
15. The Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth with Opioid Dependence. doc type
  Poole, Sabrina A. ; Pecoraro, Anna ; Subramaniam, Geetha A. ; Woody, George E. ; Vetter, Victoria
 Journal of Addiction Medicine 2016;10(1):26-33. [doi: 10.1097/ADM.0000000000000176].
 
16. Treatment Outcomes in Opioid Dependent Patients with Different Buprenorphine/Naloxone Induction Dosing Patterns and Trajectories. doc type
  Jacobs, Petra ; Ang, Alfonso ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Nielsen, Suzanne ; Wakim, Paul G. ; Mai, Barbara E. ; Mooney, Larissa J. ; Potter, Jennifer Sharpe ; Blaine, Jack D.
 American Journal on Addictions 2015;24:667-675. [doi: 10.1111/ajad.12288].
 
17. Using Behavioral Economics to Predict Outcomes of Medication and Counseling for Prescription Opioid Dependence. doc type
  Worley, Matthew J. ; Shoptaw, Steven ; Bickel, Warren K. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Phoenix, AZ, June 13-18, 2015.
 
18. Treatment Satisfaction in the CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Thomas, Christie ; Hillhouse, Maureen P. ; Ang, Alfonso ; Annon, Jeffrey J. ; Mooney, Larissa J. ; Hasson, Albert L. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Phoenix, AZ, June 13-18, 2015.
 
19. Opioid Addicted Buprenorphine Injectors: Drug Use During and After 12-Weeks of Buprenorphine-Naloxone or Methadone in the Republic of Georgia. doc type
  Piralishvili, Gvantsa ; Otiashvili, David ; Sikharulidze, Zura ; Kamkamidze, George ; Poole, Sabrina A. ; Woody, George E.
 Journal of Substance Abuse Treatment 2015;50:32-37. [doi: 10.1016/j.jsat.2014.10.003].
 
20. Alcohol Screening Among Opioid Agonist Patients in a Primary Care Clinic and an Opioid Treatment Program. doc type
  Klimas, Jan ; Muench, John ; Wiest, Katharina L. ; Croff, Raina ; Rieckmann, Traci R. ; McCarty, Dennis
 Journal of Psychoactive Drugs 2015;47(1):65-70. [doi: 10.1080/02791072.2014.991859].
 
21. Examining the Factor Structure of the Clinical Opiate Withdrawal Scale: A Secondary Data Analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003. doc type
  Barbosa-Leiker, Celestina ; McPherson, Sterling ; Mamey, Mary Rose ; Burns, G. Leonard ; Layton, Matthew E. ; Roll, John M. ; Ling, Walter
 Drug and Alcohol Dependence 2015;152:218-222. [doi: 10.1016/j.drugalcdep.2015.03.036].
 
22. Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. doc type
  Schulte, Marya T. ; Hser, Yih-Ing ; Saxon, Andrew J. ; Evans, Elizabeth ; Li, Libo ; Huang, David ; Hillhouse, Maureen P. ; Thomas, Christie ; Ling, Walter
 Journal of Community Health 2015;40(5):940-947. [doi: 10.1007/s10900-015-0016-2].
 
23. Long-term Outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Provost, Scott E. ; Fitzmaurice, Garrett M. ; McDermott, Katherine A. ; Srisarajivakul, Emily N. ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; McHugh, R. Kathryn ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2015;150:112-119. [doi: 10.1016/j.drugalcdep.2015.02.030].
 
24. Opioid Withdrawal, Craving, and Use During and After Outpatient Buprenorphine Stabilization and Taper: A Discrete Survival and Growth Mixture Model. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Walker, N. Robrina ; Weiss, Roger D. ; Trivedi, Madhukar H.
 Addictive Behaviors 2015;41:20-28. [doi: 10.1016/j.addbeh.2014.09.021].
 
25. Denial of Urinalysis-Confirmed Opioid Use in Prescription Opioid Dependence. doc type
  Hilario, E. Yvette ; Griffin, Margaret L. ; McHugh, R. Kathryn ; McDermott, Katherine A. ; Connery, Hilary Smith ; Fitzmaurice, Garrett M. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):85-90. [doi: 10.1016/j.jsat.2014.07.003].
 
26. A 'Missing Not at Random' (MNAR) and 'Missing at Random' (MAR) Growth Model Comparison with a Buprenorphine/Naloxone Clinical Trial. doc type
  McPherson, Sterling ; Barbosa-Leiker, Celestina ; Mamey, Mary Rose ; McDonell, Michael ; Enders, Craig K. ; Roll, John M.
 Addiction 2015;110(1):51-58. [doi: 10.1111/add.12714].
 
27. The Multi-Site Prescription Opioid Addiction Treatment Study: 18-Month Outcomes. doc type
  Potter, Jennifer Sharpe ; Dreifuss, Jessica A. ; Marino, Elise N. ; Provost, Scott E. ; Dodd, Dorian R. ; Rice, Lindsay S. ; Fitzmaurice, Garrett M. ; Griffin, Margaret L. ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2015;48(1):62-69. [doi: 10.1016/j.jsat.2014.07.009].
 
28. Initial Response as a Predictor of 12-Week Buprenorphine-Naloxone Treatment Response in a Prescription Opioid-Dependent Population. doc type
  McDermott, Katherine A. ; Griffin, Margaret L. ; Connery, Hilary Smith ; Hilario, E. Yvette ; Fiellin, David A. ; Fitzmaurice, Garrett M. ; Weiss, Roger D.
 Journal of Clinical Psychiatry 2015;76(2):189-194. [doi: 10.4088/JCP.14m09096].
 
29. Using Behavioral Economics to Predict Opioid Use During Prescription Opioid Dependence Treatment. doc type
  Worley, Matthew J. ; Shoptaw, Steven J. ; Bickel, Warren K. ; Ling, Walter
 Drug and Alcohol Dependence 2015;148:62-68. [doi: 10.1016/j.drugalcdep.2014.12.018].
 
30. Predictors of Long Term Opioid Withdrawal Outcome After Short-Term Stabilization with Buprenorphine. doc type
  Saleh, Mohammad I.
 European Review for Medical and Pharmacological Sciences 2014;18:3935-3942..
 
31. Association Between Hepatitis C Virus and Opioid Use While in Buprenorphine Treatment: Preliminary Findings. doc type
  Murphy, Sean M. ; Dweik, Dana ; McPherson, Sterling ; Roll, John M.
 American Journal of Drug and Alcohol Abuse 2014;41(1):88-92. [doi: 10.3109/00952990.2014.983274].
 
32. Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study. doc type
  Teruya, Cheryl ; Schwartz, Robert P. ; Mitchell, Shannon G. ; Hasson, Albert L. ; Thomas, Christie ; Buoncristiani, Samantha H. ; Hser, Yih-Ing ; Wiest, Katharina ; Cohen, Allan J. ; Glick, Naomi ; Jacobs, Petra ; McLaughlin, Paul ; Ling, Walter
 Journal of Psychoactive Drugs 2014;46(5):412-426. [doi: 10.1080/02791072.2014.921743].
 
33. Assessing Craving and Its Relationship to Subsequent Prescription Opioid Use Among Treatment-Seeking Prescription Opioid Dependent Patients. doc type
  McHugh, R. Kathryn ; Fitzmaurice, Garrett M. ; Carroll, Kathleen M. ; Griffin, Margaret L. ; Hill, Kevin P. ; Wasan, Ajay D. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2014;145:121-126. [doi: 10.1016/j.drugalcdep.2014.10.002].
 
34. Improving Treatment for Opioid Dependence: A Perspective from the Ohio Valley Node of the NIDA Clinical Trials Network. doc type
  Winstanley, Erin L. ; Brigham, Gregory S. ; Babcock, Dean ; Winhusen, Theresa M.
 Progress in Community Health Partnerships: Research, Education, and Action 2014;8(1):99-107. [doi: 10.1353/cpr.2014.0002].
 
35. Who Benefits from Additional Drug Counseling Among Prescription Opioid Dependent Patients Receiving Buprenorphine-Naloxone and Standard Medical Management? doc type
  Weiss, Roger D. ; Griffin, Margaret L. ; Potter, Jennifer Sharpe ; Dodd, Dorian R. ; Dreifuss, Jessica A. ; Connery, Hilary Smith ; Carroll, Kathleen M.
 Drug and Alcohol Dependence 2014;104(1):118-122. [doi: 10.1016/j.drugalcdep.2014.04.005].
 
36. HIV Risk Reduction with Buprenorphine-Naloxone or Methadone: Findings from A Randomized Trial. doc type
  Woody, George E. ; Bruce, R. Douglas ; Korthuis, P. Todd ; Chhatre, Sumedha ; Hillhouse, Maureen P. ; Jacobs, Petra ; Sorensen, James L. ; Saxon, Andrew J. ; Metzger, David S. ; Ling, Walter
 Journal of Acquired Immune Deficiency Syndromes 2014;66(3):288-293. [doi: 10.1097/QAI.0000000000000165].
 
37. Genetic Variation in OPRD1 and the Response to Treatment for Opioid Dependence with Buprenorphine in European American Females. doc type
  Clarke, Toni-Kim ; Crist, Richard C. ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade H.
 Pharmacogenomics Journal 2014;14:303-308. [doi: 10.1038/tpj.2013.30].
 
38. Impact of Research Network Participation on the Adoption of Buprenorphine for Substance Abuse Treatment. doc type
  Rieckmann, Traci R. ; Abraham, Amanda J. ; Kovas, Anne E. ; McFarland, Bentson H. ; Roman, Paul M.
 Addictive Behaviors 2014;39(5):889-896. [doi: 10.1016/j.addbeh.2014.01.016].
 
39. Baseline Characteristics and Treatment Outcomes in Prescription Opioid Dependent Patients With and Without Co-Occurring Psychiatric Disorder. doc type
  Griffin, Margaret L. ; Dodd, Dorian R. ; Potter, Jennifer Sharpe ; Rice, Lindsay S. ; Dickinson, William ; Sparenborg, Steven ; Weiss, Roger D.
 American Journal of Drug and Alcohol Abuse 2014;40(2):157-162. [doi: 10.3109/00952990.2013.842241].
 
40. The Relationship Between Primary Prescription Opioid and Buprenorphine-Naloxone Induction Outcomes in a Prescription Opioid Dependent Sample. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen ; Weiss, Roger D. ; Mooney, Larissa ; Potter, Jennifer Sharpe ; Lee, Joshua ; Gourevitch, Marc N. ; Ling, Walter
 American Journal on Addictions 2014;23(4):343-348. [doi: 10.1111/j.1521-0391.2013.12105.x].
 
41. Treatment Retention Among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Saxon, Andrew J. ; Huang, David ; Hasson, Albert ; Thomas, Christie ; Hillhouse, Maureen ; Jacobs, Petra ; Teruya, Cheryl ; McLaughlin, Paul ; Wiest, Katharina ; Cohen, Allan J. ; Ling, Walter
 Addiction 2014;109(1):79-87. [doi: 10.1111/add.12333].
 
42. From START to Finish: National and International Perspectives on Disseminating Research to Practice for the Treatment of Opioid Dependence. doc type
  Saxon, Andrew J. ; Woody, George E. ; Jacobs, Petra ; Crist, Richard C. ; Nurhidayat, Adhi Wibowo ; Hickman, Mathew ; Strang, John
 Blending Initiative Workshop sponsored by the National Institute on Drug Abuse (NIDA), the National Drug Abuse Treatment Clinical Trials Network (CTN), and the NIDA/SAMHSA Blending Initiative in collaboration with the American Association for the Treatment of Opioid Dependence (AATOD), Philadelphia, PA, November 10, 2013.
 
43. Psychometric Properties of the Adjective Rating Scale for Withdrawal Across Treatment Groups, Gender, and Over Time. doc type
  Barbosa-Leiker, Celestina ; McPherson, Sterling ; Marney, Mary Rose ; Burns, G. Leonard ; Roll, John M.
 Journal of Substance Abuse Treatment 2013;46(2):251-256. [doi: 10.1016/j.jsat.2013.08.020].
 
44. Lack of Association of Cannabis Use with Opioid Outcomes Among Opioid-Dependent Youth. doc type
  Hill, Kevin P. ; Bennett, Heather E. ; Griffin, Margaret L. ; Connery, Hilary Smith ; Fitzmaurice, Garrett M. ; Subramaniam, Geetha A. ; Woody, George E. ; Weiss, Roger D.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
45. Opioid Withdrawal and Craving Trajectories Following Buprenorphine Taper: A Latent Class and Growth Mixture Model of Time-to-First Opioid Lapse. doc type
  Northrup, Thomas F. ; Stotts, Angela L. ; Green, Charles ; Potter, Jennifer Sharpe ; Marino, Elise N. ; Weiss, Roger D. ; Mulpur, Swetha ; Walker, N. Robrina ; Trivedi, Madhukar H.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
46. Induction Onto Extended-Release Naltrexone in 302 Cocaine-Dependent Opioid Users. doc type
  Lindblad, Robert ; McCormack, Jennifer ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Mooney, Larissa ; VanVeldhuisen, Paul C. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
47. Concordance Between Self-Report and Urine Drug Screen Data in Adolescent Opioid Dependent Clinical Trial Participants. doc type
  Wilcox, Claire E. ; Bogenschutz, Michael P. ; Nakazawa, Masato ; Woody, George E.
 Addictive Behaviors 2013;38(10):2568-2574. [doi: 10.1016/j.addbeh.2013.05.015].
 
48. Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START). doc type
  Potter, Jennifer Sharpe ; Marino, Elise N. ; Hillhouse, Maureen P. ; Nielsen, Suzanne ; Wiest, Katharina ; Canamar, Catherine P. ; Martin, Judith A. ; Ang, Alfonso ; Baker, Rachel ; Saxon, Andrew J. ; Ling, Walter
 Journal of Studies on Alcohol and Drugs 2013;74(4):605-613..
 
49. 2013 Texas Addiction Research to Practice Conference. doc type doc type
  Stotts, Angela L. ; Walters, Scott ; Wakhlu, Sidarth
 Dissemination Conference sponsored by the Texas Node, Dallas, TX, April 26, 2013.
 
50. Transdisciplinary Collaboration and Endorsement of Pharmacological and Psychosocial Evidence-Based Practices by Medical and Psychosocial Substance Abuse Treatment Providers in the United States. doc type
  Pinto, Rogerio M. ; Spector, Anya Y. ; Yu, Gary ; Campbell, Aimee N. C.
 Drugs: Education, Prevention and Policy 2013;20(5):408-416. [doi: 10.3109/09687637.2013.783792].
 
51. Association of Cannabis Use with Opioid Outcomes Among Opioid-Dependent Youth. doc type
  Hill, Kevin P. ; Bennett, Heather E. ; Griffin, Margaret L. ; Connery, Hilary Smith ; Fitzmaurice, Garrett M. ; Subramaniam, Geetha A. ; Woody, George E. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2013;132(1-2):342-345. [doi: 10.1016/j.drugalcdep.2013.02.030].
 
52. An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans. doc type
  Crist, Richard C. ; Clarke, Toni-Kim ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade
 Neuropsychopharmacology 2013;38:2003-2010. [doi: 10.1038/npp.2013.99].
 
53. Patient Characteristics Associated with Buprenorphine/Naloxone Treatment Outcome for Prescription Opioid Dependence: Results from a Multisite Study. doc type
  Dreifuss, Jessica A. ; Griffin, Margaret L. ; Frost, Katherine ; Fitzmaurice, Garrett M. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Selzer, Jeffrey A. ; Hatch-Maillette, Mary A. ; Sonne, Susan C. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2013;131(1-2):112-118. [doi: 10.1016/j.drugalcdep.2012.12.010].
 
54. Gender Differences in a Clinical Trial for Prescription Opioid Dependence. doc type
  McHugh, R. Kathryn ; DeVito, Elise E. ; Dodd, Dorian ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Greenfield, Shelly F. ; Connery, Hilary Smith ; Weiss, Roger D.
 Journal of Substance Abuse Treatment 2013;45(1):38-43. [doi: 10.1016/j.jsat.2012.12.007].
 
55. A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ling, Walter
 Journal of Addiction Medicine 2013;7(1):33-38. [doi: 10.1097/ADM.0b013e318277e92e].
 
56. Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology. doc type
  Mooney, Larissa J. ; Nielsen, Suzanne ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Stablein, Don ; McCormack, Jennifer ; Lindblad, Robert ; Ling, Walter
 Contemporary Clinical Trials 2013;34(2):196-204. [doi: 10.1016/j.cct.2012.11.002].
 
57. Buprenorphine/Naloxone and Methadone Effects on Laboratory Indices of Liver Health: A Randomized Trial. doc type doc type
  Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ang, Alfonso ; Doraimani, Geetha ; Tasissa, Gudaye ; Lokhnygina, Yuliya ; Leimberger, Jeffrey D. ; Bruce, R. Douglas ; McCarthy, John ; Wiest, Katharina ; McLaughlin, Paul ; Bilangi, Richard ; Cohen, Allan J. ; Woody, George E. ; Jacobs, Petra
 Drug and Alcohol Dependence 2013;128(1-2):71-76. [doi: 10.1016/j.drugalcdep.2012.08.002].
 
58. Cross-System Response to the Opioid Epidemic. doc type
  Winstanley, Erin L. ; Walley, Alexander ; Brason, Fred Wells II ; Lancaster, Mike ; Davis, Corey ; Feinberg, Judith ; Roberts, Lisa ; Babcock, Dean ; Haag, Mary ; Krohn, Jo Anna
 Regional dissemination workshop sponsored by the CTN Ohio Valley Node, the Health Foundation of Greater Cincinnati, the Ohio Department of Health, and the Coalition for a Drug-Free Greater Cincinnati, November 12, 2012.
 
59. Predictors of Outcome After Short-Term Stabilization with Buprenorphine. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Ling, Walter
 Journal of Substance Abuse Treatment 2013;44(1):336-342. [doi: 10.1016/j.jsat.2012.08.016].
 
60. Financial Factors and the Implementation of Medications for Treating Opioid Use Disorders. doc type
  Knudsen, Hannah K. ; Roman, Paul M.
 Journal of Addictive Medicine 2012;6(4):280-286. [doi: 10.1097/ADM.0b013e318262a97a].
 
61. Predictors of Attrition with Buprenorphine/Naloxone Treatment in Opioid Dependent Youth. doc type
  Warden, Diane ; Subramaniam, Geetha A. ; Carmody, Thomas ; Woody, George E. ; Minhajuddin, Abu T. ; Poole, Sabrina A. ; Potter, Jennifer Sharpe ; Fishman, Marc J. ; Bogenschutz, Michael P. ; Patkar, Ashwin A. ; Trivedi, Madhukar H.
 Addictive Behaviors 2012;37(9):1046-1053. [doi: 10.1016/j.addbeh.2012.04.011].
 
62. Buprenorphine Suite of Blending Products (Blending Team Product). doc type doc type
  Blending Team Members
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2005-2012.
 
63. Advances in Clinical Research for Prescription Opioid Dependence. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D.
 Presented at the National Association of Social Workers Massachusetts Chapter Symposium, Framingham, MA, March 29-30, 2012.
 
64. Missing Data in Substance Abuse Treatment Research: Current Methods and Modern Approaches. doc type
  McPherson, Sterling ; Barbosa-Leiker, Celestina ; Burns, G. Leonard ; Howell, Donelle ; Roll, John M.
 Experimental and Clinical Psychopharmacology 2012;20(3):243-250. [doi: 10.1037/a0027146].
 
65. Compensation Effects on Clinical Trial Data Collection in Opioid-Dependent Young Adults. doc type
  Wilcox, Claire E. ; Bogenschutz, Michael P. ; Nakazawa, Masato ; Woody, George E.
 American Journal of Drug and Alcohol Abuse 2012;38(1):81-86. [doi: 10.3109/00952990.2011.600393].
 
66. Protocol: NIDA-CTN-0027: Starting Treatment with Agonist Replacement Therapies (START). doc type
  Ling, Walter ; Saxon, Andrew J.
 Presented at the American Public Health Association (APHA) annual meeting, Washington, DC, Oct. 28 - Nov. 2, 2011.
 
67. Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth. doc type
  Subramaniam, Geetha A. ; Warden, Diane ; Minhajuddin, Abu T. ; Fishman, Marc J. ; Stitzer, Maxine L. ; Adinoff, Bryon H. ; Trivedi, Madhukar H. ; Weiss, Roger D. ; Potter, Jennifer Sharpe ; Poole, Sabrina A. ; Woody, George E.
 Journal of the American Academy of Child & Adolescent Psychiatry 2011;50(11):1120-1128. [doi: 10.1016/j.jaac.2011.07.010].
 
68. Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial. doc type doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Fiellin, David A. ; Byrne, Mimmie ; Connery, Hilary Smith ; Dickinson, William ; Gardin, John G. II ; Griffin, Margaret L. ; Gourevitch, Marc N. ; Haller, Deborah L. ; Hasson, Albert L. ; Huang, Zhen ; Jacobs, Petra ; Kosinski, Andrzej S. ; Lindblad, Robert ; McCance-Katz, Elinore F. ; Provost, Scott E. ; Selzer, Jeffrey A. ; Somoza, Eugene C. ; Sonne, Susan C. ; Ling, Walter
 Archives of General Psychiatry 2011;68(12):1238-1246. [doi: 10.1001/archgenpsychiatry.2011.121].
 
69. Selective Review and Commentary on Emerging Pharmacotherapies for Opioid Addiction. doc type
  Ling, Walter ; Mooney, Larissa ; Zhao, Min ; Nielsen, Suzanne ; Torrington, Matthew ; Miotto, Karen
 Substance Abuse and Rehabilitation 2011;2:181-188. [doi: 10.2147/SAR.S20895].
 
70. Depressive Symptoms, Substance Use and HIV-Related High Risk Behaviors among Opioid-Dependent Individuals: Results from the Clinical Trials Network. doc type
  Pilowsky, Daniel J. ; Wu, Li-Tzy ; Burchett, Bruce ; Blazer, Dan G. ; Ling, Walter
 Substance Use & Misuse 2011;46(14):1716-1725. [doi: 10.3109/10826084.2011.611960].
 
71. Barriers to Implementing MAT. doc type
  Winstanley, Erin L.
 Presented at the South Dakota Association of Addiction & Prevention Specialists conference, Mitchell, SD, September 28-30, 2011.
 
72. Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial. doc type
  Back, Sudie E. ; Payne, Rebecca ; Wahlquist, Amy Herrin ; Carter, Rickey E. ; Stroud, Zachary ; Haynes, Louise F. ; Hillhouse, Maureen P. ; Brady, Kathleen T. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):313-323. [doi: 10.3109/00952990.2011.596982].
 
73. Participant Characteristics and Buprenorphine Dose. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Doraimani, Geetha ; Thomas, Christie ; Hasson, Albert L. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):453-459. [doi: 10.3109/00952990.2011.596974].
 
74. NIDA’s Clinical Trials Network: An Opportunity for HIV Research in Community Substance Abuse Treatment Programs. doc type
  Tross, Susan ; Campbell, Aimee N. C. ; Calsyn, Donald A. ; Metsch, Lisa R. ; Sorensen, James L. ; Shoptaw, Steven ; Haynes, Louise F. ; Woody, George E. ; Malow, Robert M. ; Brown, Lawrence S. Jr. ; Feaster, Daniel J. ; Booth, Robert E. ; Mandler, Raul N. ; Masson, Carmen L. ; Holmes, Beverly W. ; Colfax, Grant N. ; Brooks, Audrey J. ; Hien, Denise A. ; Schackman, Bruce R. ; Korthuis, P. Todd ; Miele, Gloria M.
 American Journal of Drug and Alcohol Abuse 2011;37(5):283-293. [doi: 10.3109/00952990.2011.596977].
 
75. A Multi-Level Analysis of Counselor Attitudes Toward the Use of Buprenorphine in Substance Abuse Treatment. doc type
  Rieckmann, Traci R. ; Kovas, Anne E. ; McFarland, Bentson H. ; Abraham, Amanda J.
 Journal of Substance Abuse Treatment 2011;41(4):374-385. [doi: 10.1016/j.jsat.2011.05.005].
 
76. Co-Occurring Amphetamine Use and Associated Medical and Psychiatric Comorbidity Among Opioid-Dependent Adults: Results from the Clinical Trials Network. doc type
  Pilowsky, Daniel J. ; Wu, Li-Tzy ; Burchett, Bruce ; Blazer, Dan G. ; Woody, George E. ; Ling, Walter
 Substance Abuse and Rehabilitation 2011;2:133-144. [doi: 10.2147/SAR.S20895].
 
77. Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction Treatment Study. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Griffin, Margaret L. ; Connery, Hilary Smith ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Hollywood, FL, June 18-23, 2011.
 
78. Cocaine Use Reduction with Buprenorphine (CURB: CTN-0048): Protocol Overview. doc type
  Mooney, Larissa ; Saxon, Andrew J. ; Ling, Walter
 Webinar sponsored by the NIDA Clinical Coordinating Center, May 11, 2011.
 
79. Using Medication-Assisted Treatment for Substance Use Disorders: Evidence of Barriers and Facilitators of Implementation. doc type
  Roman, Paul M. ; Abraham, Amanda J. ; Knudsen, Hannah K.
 Addictive Behaviors 2011;36(6):584-589. [doi: 10.1016/j.addbeh.2011.01.032].
 
80. Clinical Correlates of Health-Related Quality of Life Among Opioid-Dependent Patients. doc type
  Heslin, Kevin C. ; Stein, Judith A. ; Heinzerling, Keith G. ; Pan, Deyu ; Magladry, Christine ; Hays, Ron D.
 Quality of Life Research 2011;20(8):1205-1213. [doi: 10.1007/s11136-011-9858-y].
 
81. What the National Institute on Drug Abuse's Clinical Trials Network Can Do For You? Major Findings from Medication Trials and Implications for Community-Based Settings. doc type
  Weiss, Roger D.
 Presented at the NIATx Summit and State Associations of Addiction Services (SAAS) National Conference, Boston, MA, July 19-22, 2011.
 
82. A Community-Based, Two-Phase Randomized Controlled Trial of Buprenorphine With and Without Individual Drug Counseling for the Treatment of Opioid Analgesic Addiction. doc type
  Provost, Scott E. ; Potter, Jennifer Sharpe ; Weiss, Roger D. ; Jacobs, Petra ; Ling, Walter
 Poster presented at the American Public Health Association (APHA) Annual Meeting, Denver, CO, November 6-10, 2010..
 
83. NIDA Clinical Trials Network: Examples of Community Program Buprenorphine Dissemination in Low-Access Areas. doc type
  Connery, Hilary Smith ; Publicker, Mark ; Hoyne, Jim ; Cohan, Allison ; Provost, Scott E. ; Woody, George E. ; Weiss, Roger D.
 Poster presented at the American Academy of Addiction Psychiatry (AAAP) annual meeting, Boca Raton, FL, December 2-5, 2010.
 
84. Data from the CTN Platform Study: Major Findings. doc type
  Roman, Paul M. ; Abraham, Amanda J.
 Presentation from the CTN Steering Committee Meeting, March 2009; CTN 10th Anniversary Symposium, 2010, and the CTN Steering Committee Meeting, September 2010.
 
85. Gender and Racial/Ethnic Differences in Addiction Severity, HIV Risk, and Quality of Life among Adults in Opioid Detoxification: Results from the National Drug Abuse Treatment Clinical Trials Network. doc type
  Wu, Li-Tzy ; Ling, Walter ; Burchett, Bruce ; Blazer, Dan G. ; Shostak, Jack ; Woody, George E.
 Substance Abuse and Rehabilitation 2010;1:13-22. [doi: 10.2147/SAR.S15151].
 
86. Cost-Effectiveness of Extended Buprenorphine-Naloxone Treatment for Opioid-Dependent Youth: Data from a Randomized Trial. doc type
  Polsky, Daniel ; Glick, Henry A. ; Yang, Jianing ; Subramaniam, Geetha A. ; Poole, Sabrina A. ; Woody, George E.
 Addiction 2010;105(9):1616-1624. [doi: 10.1111/j.1360-0443.2010.03001.x].
 
87. Counselor Attitudes toward Buprenorphine in the Clinical Trials Network. doc type
  Knudsen, Hannah K. ; Roman, Paul M.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
88. Effects of Participant Compensation Amounts on Missing Data and Urine Screen Results Among Adolescent and Young Adult Opioid Dependent Clinical Trial Participants. doc type
  Wilcox, Claire E. ; Bogenschutz, Michael P. ; Nakazawa, Masato ; Woody, George E.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
89. Craving Intensity and Withdrawal Severity Across Phases of Opioid Detoxification with Buprenorphine. doc type
  Chen, Hanhui ; Hillhouse, Maureen P. ; Doraimani, Geetha ; Hasson, Albert L. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
90. START Study Retention: Perspectives of Suboxone Dropouts. doc type
  Teruya, Cheryl ; Thomas, Christie ; Rosensteel, Anya ; Hasson, Albert L. ; Hillhouse, Maureen P. ; Hser, Yih-Ing ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
91. Concordance Between Self-Report and Urine Drug Screen Data in Adolescent Opioid Dependent Clinical Trial Participants. doc type
  Nakazawa, Masato ; Wilcox, Claire E. ; Bogenschutz, Michael P. ; Woody, George E.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
92. Implementing Research in Community Treatment Programs: Findings from a CTN Trial. doc type
  Cohen, Allan J. ; George, Dan ; Langlois, Camille ; Moreno, Ann ; Yomjinda, Dara ; Boubion, Cynthia ; Martin, Judith ; Donovick, Roger ; Thomas, Christie ; Hasson, Albert L. ; Vimieiro, Cintia ; Hillhouse, Maureen P. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
93. Association of Race and Ethnicity with Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy. doc type
  Brown, E. Sherwood ; Tirado, Carlos F. ; Minhajuddin, Abu T. ; Hillhouse, Maureen P. ; Adinoff, Bryon H. ; Ling, Walter ; Doraimani, Geetha ; Thomas, Christie
 Journal of Ethnicity in Substance Abuse 2010;9(2):106-114. [doi: 10.1080/15332641003772587].
 
94. Extended vs. Short-Term Buprenorphine/Naloxone for Treatment of Opioid-Addicted Youth. doc type
  Woody, George E. ; Poole, Sabrina A. ; Subramaniam, Geetha A. ; Dugosh, Karen L. ; Bogenschutz, Michael P. ; Abbott, Patrick J.
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
95. Feasibility of Conducting Genetics Research at Community Treatment Programs. doc type
  Sonne, Susan C. ; Gentilin, Stephanie ; Sampson, Royce ; DeVane, Lindsay ; Thomas, Christie ; Berrettini, Wade
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
96. The Internal and External Impacts of the Clinical Trials Network: A View from a Longitudinal Platform Study. doc type
  Roman, Paul M. ; Abraham, Amanda J. ; Knudsen, Hannah K. ; Ducharme, Lori J. ; Rothrauff, Tanja C. ; Savage, Sarah A.
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
97. Cost-Effectiveness of Extended Buprenorphine/Naloxone Treatment for Opioid Dependent Youth: Data from a Randomized Trial. doc type
  Polsky, Daniel ; Glick, Henry A. ; Yang, Jianing ; Subramaniam, Geetha A. ; Poole, Sabrina A. ; Woody, George E.
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
98. Adoption of Medication Treatment for Adolescent and Young Adult Opioid Dependence. doc type
  Fishman, Marc J. ; Khan, Lawangeen ; Garrett, Shannon ; O'Neill, Lawrence ; Hiken, Lauren ; Shah, Syed ; Bokhari, Asad
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
99. Predictors of Buprenorphine-Naloxone Dosing in a 12-Week Treatment Trial for Opioid-Dependent Youth: Secondary Analyses from a NIDA Clinical Trials Network Study. doc type
  Weiss, Roger D. ; Chakrabarti, Amit ; Woody, George E. ; Griffin, Margaret L. ; Subramaniam, Geetha A. ; Dodd, Dorian R.
 Presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
100. CTN Pharmacotherapy Trials and the CTP. doc type
  Cohen, Allan J.
 Presented at the CTN 10th Anniversary Symposium, Albuquerque, NM, April 21, 2010.
 
101. Adoption of Evidence-Based Practices in the CTN. doc type
  Roman, Paul M. ; Abraham, Amanda J.
 Presented at the CTN 10th Anniversary Symposium, Albuquerque, NM, April 21, 2010.
 
102. Ten Years of Pharmacotherapy Trials in the CTN: An Overview. doc type
  Brady, Kathleen T.
 Presented at the CTN 10th Anniversary Symposium, Albuquerque, NM, April 21, 2010.
 
103. Buprenorphine Treatment for Young Adults (Blending Team Product). doc type
  McNicholas, Laura F. ; Bogenschutz, Michael P. ; Subramaniam, Geetha A. ; Garrett, Shannon ; Storti, Susan A. ; Woody, George E. ; Freese, Thomas E. ; Waters, Pamela ; Durham, Thomas
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2010.
 
104. HIV Risk Behavior in Treatment-Seeking Opioid-Dependent Youth: Results from a NIDA Clinical Trials Network Multisite Study. doc type
  Meade, Christina S. ; Weiss, Roger D. ; Fitzmaurice, Garrett M. ; Poole, Sabrina A. ; Subramaniam, Geetha A. ; Patkar, Ashwin A. ; Connery, Hilary Smith ; Woody, George E.
 Journal of Acquired Immune Deficiency Syndromes 2010;55(1):65-72. [doi: 10.1097/QAI.0b013e3181d916db].
 
105. Buprenorphine Treatment of Prescription Opiate Addiction. doc type
  McCarthy, John
 Presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
106. Young Opioid Abusers Benefit from Extended Buprenorphine-Naloxone Treatment. doc type
  Whitten, Lori
 NIDA Notes 2010;23(1):8-9.
 
107. The First Decade of the National Drug Abuse Treatment Clinical Trials Network: Bridging the Gap Between Research and Practice to Improve Drug Abuse Treatment. doc type
  Tai, Betty ; Straus, Michele M. ; Liu, David S. ; Sparenborg, Steven ; Jackson, T. Ronald ; McCarty, Dennis
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S4-S13. [doi: 10.1016/j.jsat.2010.01.011].
 
108. Study Results from the Clinical Trials Network's First 10 Years: Where Do They Lead? doc type
  Wells, Elizabeth A. ; Saxon, Andrew J. ; Calsyn, Donald A. ; Jackson, T. Ronald ; Donovan, Dennis M.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S14-S30. [doi: 10.1016/j.jsat.2009.12.009].
 
109. Partnerships and Pathways of Dissemination: The National Institute on Drug Abuse - Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network. doc type
  Martino, Steve ; Brigham, Gregory S. ; Higgins, Christine ; Gallon, Steve ; Freese, Thomas E. ; Albright, Lonnetta M. ; Hulsey, Eric G. ; Krom, Laurie ; Storti, Susan A. ; Perl, Harold I. ; Nugent, Cathrine D. ; Pintello, Denise ; Condon, Timothy P.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S31-S43. [doi: 10.1016/j.jsat.2009.12.013].
 
110. A Longitudinal Study of Organizational Formation, Innovation of Adoption, and Dissemination Activities within the National Drug Abuse Treatment Clinical Trials Network. doc type
  Roman, Paul M. ; Abraham, Amanda J. ; Rothrauff, Tanja C. ; Knudsen, Hannah K.
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S44-S52. [doi: 10.1016/j.jsat.2009.12.008].
 
111. From Research to the Real World: Buprenorphine in the Decade of the Clinical Trials Network. doc type
  Ling, Walter ; Jacobs, Petra ; Hillhouse, Maureen P. ; Hasson, Albert L. ; Thomas, Christie ; Freese, Thomas E. ; Sparenborg, Steven ; McCarty, Dennis ; Weiss, Roger D. ; Saxon, Andrew J. ; Cohen, Allan J. ; Straus, Michele M. ; Brigham, Gregory S. ; Liu, David S. ; McLaughlin, Paul ; Tai, Betty
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S53-S60. [doi: 10.1016/j.jsat.2010.01.009].
 
112. Pain and Continued Opioid Use in Individuals Receiving Buprenorphine-Naloxone for Opioid Detoxification: Secondary Analyes from the Clinical Trials Network. doc type
  Potter, Jennifer Sharpe ; Chakrabarti, Amit ; Domier, Catherine P. ; Hillhouse, Maureen P. ; Weiss, Roger D. ; Ling, Walter
 Journal of Substance Abuse Treatment 2010;38(suppl 1):S80-S86. [doi: 10.1016/j.jsat.2009.12.007].
 
113. Provision of Ancillary Medications During Buprenorphine Detoxification Does Not Improve Treatment Outcomes. doc type
  Hillhouse, Maureen P. ; Domier, Catherine P. ; Chim, David ; Ling, Walter
 Journal of Addictive Diseases 2010;29(1):23-29. [doi: 10.1080/10550880903438925].
 
114. A Method to Diagnose Opioid Dependence Resulting from Heroin Versus Prescription Opioids Using the Composite International Diagnostic Interview. doc type
  Potter, Jennifer Sharpe ; Prather, Kristi ; Kropp, Frankie B. ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Mohamedi, Nadia ; Copersino, Marc L. ; Weiss, Roger D.
 Contemporary Clinical Trials 2010;31(2):185-188. [doi: 10.1016/j.cct.2010.01.002].
 
115. Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Copersino, Marc L. ; Prather, Kristi ; Jacobs, Petra ; Provost, Scott E. ; Chim, David ; Selzer, Jeffrey A. ; Ling, Walter
 American Journal on Addictions 2010;19(2):141-146. [doi: 10.1111/j.1521-0391.2009.00017.x].
 
116. Effects of Buprenorphine and Hepatitis C on Liver Enzymes in Adolescents and Young Adults. doc type
  Bogenschutz, Michael P. ; Abbott, Patrick J. ; Kushner, Robert ; Tonigan, J. Scott ; Woody, George E.
 Journal of Addiction Medicine 2010;4(4):211-216. [doi: 10.1097/ADM.0b013e3181c4e27e].
 
117. A Multi-Site, Two-Phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, Design, and Methodology. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Provost, Scott E. ; Huang, Zhen ; Jacobs, Petra ; Hasson, Albert L. ; Lindblad, Robert ; Connery, Hilary Smith ; Prather, Kristi ; Ling, Walter
 Contemporary Clinical Trials 2010;31(2):189-199. [doi: 10.1016/j.cct.2010.01.003].
 
118. Predictors of Buprenorphine-Naloxone Dosing in a 12-Week Treatment Trial for Opioid-Dependent Youth: Secondary Analyses from a NIDA Clinical Trials Network Study. doc type
  Chakrabarti, Amit ; Woody, George E. ; Griffin, Margaret L. ; Subramaniam, Geetha A. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2010;107(2-3):253-256. [doi: 10.1016/j.drugalcdep.2009.10.014].
 
119. Gender Differences at Presentation for Treatment-Seeking Opiate Dependence. doc type
  Haynes, Louise F. ; Carter, Rickey E. ; Back, Sudie E. ; Payne, Rebecca ; Hillhouse, Maureen P.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
120. Methods for Disseminating Evidence-Based Treatments from the Frontlines of Community Treatment Programs. doc type doc type doc type
  Brigham, Gregory S. ; Peterson, Lori ; Higgins, Christine ; Douaihy, Antoine B. ; Chambers, Sharon ; Kristman-Valente, Allison ; Trani, Christina ; Mosel, Linda ; Brunner, Meg
 Workshop held at the CTN Steering Committee meeting, Bethesda, MD, March 24, 2009.
 
121. Buprenorphine Adoption in the National Drug Abuse Treatment Clinical Trials Network. doc type
  Knudsen, Hannah K. ; Abraham, Amanda J. ; Johnson, J. Aaron ; Roman, Paul M.
 Journal of Substance Abuse Treatment 2009;37(3):307-312. [doi: 10.1016/j.jsat.2008.12.004].
 
122. Use of an Adaptive Treatment Research Design in a CTN Study of Prescription Opioid Dependence Treatment. doc type
  Weiss, Roger D. ; Potter, Jennifer Sharpe ; Byrne, Mimmie ; Sullivan, Carl Rollynn ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
123. Clinical Characteristics of Treatment-Seeking Prescription Opioid vs. Heroin-Using Adolescents with Opioid Use Disorder. doc type
  Subramaniam, Geetha A. ; Stitzer, Maxine L.
 Drug and Alcohol Dependence 2009;101(1-2):13-19. [doi: 10.1016/j.drugalcdep.2008.10.015].
 
124. Clinical Characteristics of Treatment-Seeking Adolescents with Opioid versus Cannabis/Alcohol Use Disorders. doc type
  Subramaniam, Geetha A. ; Stitzer, Maxine L. ; Woody, George E. ; Fishman, Marc J. ; Kolodner, Ken B.
 Drug and Alcohol Dependence 2009;99(1-3):141-149. [doi: 10.1016/j.drugalcdep.2008.07.016].
 
125. Predictors of Outcome for Short-Term Medically Supervised Opioid Withdrawal During a Randomized, Multicenter Trial of Buprenorphine-Naloxone and Clonidine in the NIDA Clinical Trials Network. doc type
  Ziedonis, Douglas M. ; Amass, Leslie ; Steinberg, Marc ; Woody, George E. ; Krejci, Jonathan ; Annon, Jeffrey J. ; Cohen, Allan J. ; Waite-O'Brien, Nancy ; Stein, Susan M. ; McCarty, Dennis ; Reid, Malcolm S. ; Brown, Lawrence S. Jr. ; Maslansky, Robert ; Winhusen, Theresa M. ; Babcock, Dean ; Brigham, Gregory S. ; Muir, Joan A. ; Orr, Deborah ; Buchan, Betty J. ; Horton, Terry ; Ling, Walter
 Drug and Alcohol Dependence 2009;99(1-3):28-36. [doi: 10.1016/j.drugalcdep.2008.06.016].
 
126. Buprenorphine Tapering Schedule and Illicit Opioid Use. doc type doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Domier, Catherine P. ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert L. ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard
 Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x].
 
127. Extended vs. Short-Term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth: A Randomized Trial. doc type doc type
  Woody, George E. ; Poole, Sabrina A. ; Subramaniam, Geetha A. ; Dugosh, Karen L. ; Bogenschutz, Michael P. ; Abbott, Patrick J. ; Patkar, Ashwin A. ; Publicker, Mark ; McCain, Karen ; Potter, Jennifer Sharpe ; Forman, Robert F. ; Vetter, Victoria ; McNicholas, Laura F. ; Blaine, Jack D. ; Lynch, Kevin G. ; Fudala, Paul
 JAMA 2008;300(17):2003-2011. [doi: 10.1001/jama.2008.574].
 
128. Opioid Treatment Programs in the Clinical Trials Network: Representativeness and Buprenorphine Adoption. doc type
  Ducharme, Lori J. ; Roman, Paul M.
 Journal of Substance Abuse Treatment 2009;37(1):90-94. [doi: 10.1016/j.jsat.2008.09.003].
 
129. Changes in 12-Step Cognitions Among Treatment-Seeking Adolescents. doc type
  Tonigan, J. Scott ; Forcehimes, Alyssa A. ; Bogenschutz, Michael P.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Juan, Puerto Rico, June 14-19, 2008.
 
130. Effects of Buprenorphine and Hepatitis C on Liver Enzymes in Adolescents and Young Adults. doc type
  Bogenschutz, Michael P. ; Kushner, Robert ; Tonigan, J. Scott ; Woody, George E.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Juan, Puerto Rico, June 14-19, 2008.
 
131. Relationship Between Therapeutic Alliance and Treatment Outcome in Opioid Dependent Adolescents and Young Adults Treated with Buprenorphine. doc type
  Forcehimes, Alyssa A. ; Bogenschutz, Michael P. ; Tonigan, J. Scott ; Woody, George E.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Juan, Puerto Rico, June 14-19, 2008.
 
132. Understanding and Utilizing Buprenorphine in the Treatment and Short Term Detox of Opioid Addiction. doc type
  Freese, Thomas E. ; Detmer, Mary Ann ; Brigham, Gregory S.
 Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008.
 
133. Addiction Treatments of the Future: The Role of Genetics. doc type
  Kreek, Mary Jeanne ; Haynes, Louise F. ; Cohen, Allan J.
 Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008.
 
134. Statistical Methodology for a SMART Design in the Development of Adaptive Treatment Strategies. doc type
  Scott, Alena I. ; Levy, Janet A. ; Murphy, Susan A.
 State College, PA : The Methodology Center, Pennsylvania State University, Technical Report #07-82, 2007, 30p..
 
135. Integrating Services Research into CTN Clinical Trials: The Synergy is in the Details. doc type
  Perl, Harold I.
 Presented at the Addiction Health Services Research Conference, October 15-17, 2007, Athens, GA.
 
136. A Federal Effort to Bridge the Gap: NIDA's Blending Initiative Places Community Providers at the Leading Edge of New Treatment Knowledge. doc type
  Condon, Timothy P.
 Addiction Professional 2007;5(5):26-31.
 
137. The Science of Treatment: Dissemination of Research-Based Drug Addiction Treatment Findings (Blending Team Product). doc type
  National Institute on Drug Abuse (NIDA) ; Substance Abuse and Mental Health Services Administration (SAMHSA) ; Addiction Technology Transfer Center (ATTC) National Office
 Produced by the NIDA/SAMHSA-ATTC Blending Initiative, 2007.
 
138. Research Network Involvement and Addiction Treatment Center Staff: Counselor Attitudes toward Buprenorphine. doc type
  Knudsen, Hannah K. ; Ducharme, Lori J. ; Roman, Paul M.
 American Journal on Addictions 2007;16(5):365-371 [doi: 10.1080/10550490701525418].
 
139. The Value of Ongoing Evaluation in Adopting Buprenorphine-Naloxone Short-Term Taper. doc type
  Brigham, Gregory S.
 Presented at the American Psychological Association (APA) Annual Convention, San Francisco, CA, August 17-20, 2007.
 
140. Innovation Adoption in Substance Abuse Treatment: Exposure, Trialability, and the Clinical Trials Network. doc type
  Ducharme, Lori J. ; Knudsen, Hannah K. ; Roman, Paul M. ; Johnson, J. Aaron
 Journal of Substance Abuse Treatment 2007;32:321-329. [doi: 10.1016/j.jsat.2006.05.021].
 
141. Using Buprenorphine to Facilitate Entry into Residential Therapeutic Community Rehabilitation. doc type
  Collins, Eric D. ; Horton, Terry ; Reinke, Katherine ; Amass, Leslie ; Nunes, Edward V.
 Journal of Substance Abuse Treatment 2007;32(2):167-175. [doi: 10.1016/j.jsat.2006.03.018].
 
142. Using Buprenorphine Short-Term Taper to Facilitate Early Treatment Engagement. doc type
  Brigham, Gregory S. ; Amass, Leslie ; Winhusen, Theresa M. ; Harrer, Judith M. ; Pelt, Alvin
 Journal of Substance Abuse Treatment 2007;32(4):349-356. [doi: 10.1016/j.jsat.2006.09.006].
 
143. Starting Treatment with Agonist Replacement Therapy: Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 Bethesda, MD: National Institute on Drug Abuse, 2006.
 
144. Clinical Trials Network: Counselor-Level Data on Evidence-Based Treatment Practices. doc type
  Roman, Paul M. ; Johnson, J. Aaron ; Ducharme, Lori J. ; Knudsen, Hannah K.
 Atlanta, GA: Institute for Behavioral Research, University of Georgia, NTCS Report No. 11, February 2006, 44p..
 
145. The Clinical Trials Network and Treatment Innovations: Differences in Counselor Attitudes toward Buprenorphine. doc type
  Knudsen, Hannah K. ; Ducharme, Lori J. ; Roman, Paul M. ; Johnson, J. Aaron
 Poster presented at the College on Problems of Drug Dependence annual meeting, June 17-22, 2006.
 
146. Using Buprenorphine in Opioid Treatment Programs. doc type
  Cohen, Allan J.
 Presented at the American Association for the Treatment of Opioid Dependence (AATOD) annual meeting, Atlanta, GA, April 2006.
 
147. Short Term Opioid Withdrawal Using Buprenorphine (Blending Team Product). doc type
  Freese, Thomas E. ; Brigham, Gregory S. ; Finnerty, Beth ; Gresham-Morrison, Kay ; Harrer, Judith M. ; McCarty, Dennis ; Storti, Susan A.
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2006.
 
148. Challenges in the Adoption of New Pharmacotherapeutics for Addiction to Alcohol and Other Drugs. doc type
  Saxon, Andrew J. ; McCarty, Dennis
 Pharmacology & Therapeutics 2005;108:119-128. [doi: 10.1016/j.pharmthera.2005.06.014].
 
149. Prescription Opioid Addiction Treatment Study: Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
150. A Multi-Center Randomized Trial of Buprenorphine-Naloxone Versus Clonidine for Opioid Detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. doc type doc type
  Ling, Walter ; Amass, Leslie ; Shoptaw, Steven ; Annon, Jeffrey J. ; Hillhouse, Maureen P. ; Babcock, Dean ; Brigham, Gregory S. ; Harrer, Judith M. ; Reid, Malcolm S. ; Muir, Joan A. ; Buchan, Betty J. ; Orr, Deborah ; Woody, George E. ; Krejci, Jonathan ; Ziedonis, Douglas M. ; CTN Buprenorphine Study Team (CTN-0001/0002)
 Addiction 2005; 100(8):1090-1100. [doi: 10.1111/j.1360-0443.2005.01154.x] Correction: Addiction 2006;101(9):1374.
 
151. Buprenorphine Treatment: A Training for Multidisciplinary Addiction Professionals (Blending Team Product) doc type doc type
  Amass, Leslie ; Brigham, Gregory S. ; Clare, Glenda ; Dixon, Gail ; Finnerty, Beth ; Freese, Thomas E. ; Strain, Eric ; Martin, Judith ; McCann, Michael J. ; Obert, Jeanne L. ; Wesson, Donald ; Addiction Technology Transfer Center (ATTC) National Office ; OASIS Clinic
 Produced by a NIDA/SAMHSA-ATTC Blending Team, 2005.
 
152. Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience. doc type
  Amass, Leslie ; Ling, Walter ; Freese, Thomas E. ; Reiber, Chris ; Annon, Jeffrey J. ; Cohen, Allan J. ; McCarty, Dennis ; Reid, Malcolm S. ; Brown, Lawrence S. Jr. ; Clark, Cynthia ; Ziedonis, Douglas M. ; Krejci, Jonathan ; Stine, Susan M. ; Winhusen, Theresa M. ; Brigham, Gregory S. ; Babcock, Dean ; Muir, Joan A. ; Buchan, Betty J. ; Horton, Terry
 American Journal on Addictions 2004; 13 (Suppl 1): S42-S66. [doi: 10.1080/10550490490440807].
 
153. Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults : Version III(i), August 14, 2003. doc type
  Woody, George E. ; Forman, Robert F. ; Poole, Sabrina A.
 Presented on August 14, 2003..
 
154. Bup/Nx and Clonidine: A Medication Comparison Study. Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
155. Bup/Nx and Clonidine: A Medication Comparison Study. Now That I Have Joined. . . doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
156. Buprenorphine/Naloxone versus Clonidine for Opiate Detoxification : A Medication Comparison Study. Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
157. Buprenorphine/Naloxone versus Clonidine for Opiate Detoxification : A Medication Comparison Study. Now That I've Joined. . . doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
158. Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules. Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 

New Search